Aptus Pharma Ltd. IPO

Aptus Pharma Ltd. is listed in the SME segment. The figures below are as reported by the exchanges and public sources.

Aptus Pharma Ltd. IPO — key facts

• As of 5 September 2026, the Aptus Pharma Ltd. IPO subscription status is 22.27x overall.
• The issue is open from 23-Sep-2025 to 25-Sep-2025.
• Aptus Pharma Ltd. listed on 30-Sep-2025.
• Aptus Pharma Ltd. listed at ₹84.84. The listing gain was 21.2% against the upper end of the issue price band.

Aptus Pharma Ltd. IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price

₹70

Issue size

₹13.02 Cr

Fresh issue

₹12.36 Cr

Opens

23-Sep-2025

Closes

25-Sep-2025

Listing

30-Sep-2025

Total subscription

22.27x

Retail

31.43x

QIB

1.24x

NII

28.75x

Lead managers

Interactive Financial

Listing price

₹84.84

Listing day change

+21.2%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.